Literature DB >> 7180027

The role of herd immunity in control of measles.

F L Black.   

Abstract

Measles vaccine cannot give high sero-conversion rates in developing countries. The high birth rates characteristic of these countries lead to infection at a very early age, thus making it difficult to vaccinate before exposure to the disease. Nevertheless, if given early in life, the vaccine can reduce the rate of virus circulation and thus raise the age at which children are infected. Once that is done, higher sero-conversion rates can be obtained by raising the age at vaccination. During the period when vaccine is given at an early age, the titers in responding children will be low, and this will leave children of the next generation with little protection. It is important, therefore, that if vaccine is used early the program be intensively and consistently applied to control virus circulation before the next generation is born.

Entities:  

Keywords:  Age Factors; Biology; Child Health; Communicable Disease Control; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Health; Health Services; Immunity; Immunization; Measles--prevention and control; Medicine; Physiology; Population; Population Characteristics; Preventive Medicine; Primary Health Care; Public Health; Vaccination; Viral Diseases

Mesh:

Substances:

Year:  1982        PMID: 7180027      PMCID: PMC2596463     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  11 in total

1.  Measles immunity in children vaccinated before one year of age.

Authors:  A Schluederberg; S H Lamm; P J Landrigan; F L Black
Journal:  Am J Epidemiol       Date:  1973-06       Impact factor: 4.897

2.  Measles antibody in previously immunized children. The need for revaccination.

Authors:  C C Linnemann; M S Dine; J E Bloom; G M Schiff
Journal:  Am J Dis Child       Date:  1972-07

3.  Live, further attenuated rubella vaccine. Serologic responses among term and low birth weight infants.

Authors:  J Wilkins; P F Wehrle; B Portnoy
Journal:  Am J Dis Child       Date:  1972-03

4.  Reported measles in persons immunologically primed by prior vaccination.

Authors:  F R Smith; A S Curran; K A Raciti; F L Black
Journal:  J Pediatr       Date:  1982-09       Impact factor: 4.406

5.  Measles and measles vaccine isolated amerindian tribes. I. The 1971 Trio ((Tiriyo) epidemic.

Authors:  J van Mazijk; F P Pinheiro; F L Black
Journal:  Trop Geogr Med       Date:  1982-03

6.  Measles revaccination. Persistence and degree of antibody titer by type of immune response.

Authors:  J Deseda-Tous; J D Cherry; M J Spencer; R C Welliver; K M Boyer; J P Dudley; J M Zahradnik; P J Krause; E W Walbergh
Journal:  Am J Dis Child       Date:  1978-03

7.  Measles immunity after revaccination: results in children vaccinated before 10 months of age.

Authors:  C C Linnemann; M S Dine; G A Roselle; P A Askey
Journal:  Pediatrics       Date:  1982-03       Impact factor: 7.124

8.  Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.

Authors:  R G Baruzzi; N Abdala; F L Black
Journal:  Trop Geogr Med       Date:  1982-03

9.  Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization.

Authors:  J Wilkins; P F Wehrle
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

10.  The half-life on homologous gamma globulin (antibody) in several species.

Authors:  F J DIXON; D W TALMAGE; P H MAURER; M DEICHMILLER
Journal:  J Exp Med       Date:  1952-05       Impact factor: 14.307

View more
  12 in total

1.  Loss of maternally acquired measles antibodies in well-nourished infants and response to measles vaccination, Peru.

Authors:  A Vaisberg; J O Alvarez; H Hernandez; D Guillen; P Chu; A Colarossi
Journal:  Am J Public Health       Date:  1990-06       Impact factor: 9.308

2.  Conserved patterns of incomplete reporting in pre-vaccine era childhood diseases.

Authors:  Christian E Gunning; Erik Erhardt; Helen J Wearing
Journal:  Proc Biol Sci       Date:  2014-11-07       Impact factor: 5.349

3.  Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination.

Authors:  F L Black; L L Berman; M Libel; C A Reichelt; F D Pinheiro; A Travassos da Rosa; F Figueira; E Siqueira Gonzales
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

4.  Measles in developing countries. Part II. The predicted impact of mass vaccination.

Authors:  A R McLean; R M Anderson
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

5.  Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.

Authors:  P Kiepiela; H M Coovadia; W E Loening; P Coward; G Botha; J Hugo; P J Becker
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

6.  Probabilistic measures of persistence and extinction in measles (meta)populations.

Authors:  Christian E Gunning; Helen J Wearing
Journal:  Ecol Lett       Date:  2013-06-20       Impact factor: 9.492

7.  The role of vaccination coverage, individual behaviors, and the public health response in the control of measles epidemics: an agent-based simulation for California.

Authors:  Fengchen Liu; Wayne T A Enanoria; Jennifer Zipprich; Seth Blumberg; Kathleen Harriman; Sarah F Ackley; William D Wheaton; Justine L Allpress; Travis C Porco
Journal:  BMC Public Health       Date:  2015-05-01       Impact factor: 3.295

8.  Trends in childhood measles vaccination highlight socioeconomic inequalities in Vietnam.

Authors:  Vu Duy Kien; Hoang Van Minh; Kim Bao Giang; Vu Quynh Mai; Ngo Tri Tuan; Mikkel B Quam
Journal:  Int J Public Health       Date:  2016-10-01       Impact factor: 3.380

9.  The Role of Experts in the Covid-19 Pandemic and the Limits of Their Epistemic Authority in Democracy.

Authors:  Andrea Lavazza; Mirko Farina
Journal:  Front Public Health       Date:  2020-07-14

Review 10.  Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.

Authors:  Asha Shelly; Priya Gupta; Rahul Ahuja; Sudeepa Srichandan; Jairam Meena; Tanmay Majumdar
Journal:  Viruses       Date:  2020-10-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.